Our data have shown that Grhl2 and Wnt7A1 promote epithelial gene expression and tumor progression while Wnt7A2 promotes EMT but inhibits tumor progression, suggesting that 4T1 tumor progression in vivo might be associated with the epithelial phenotype. Here, GRHL2 is linked to neoplasm.